Q2 2026 Holdings
Filed 2026-08-11 | 463 holdings | $429.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $490.2K | 62,442 | 0.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $491.8K | 3,705 | 0.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $492.8K | 37,055 | 0.1% |
| Carlyle Secured Lending Inc(CGBD) | COM | 872280102 | $493.4K | 46,857 | 0.1% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $506.8K | 5,474 | 0.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $508.7K | 9,215 | 0.1% |
| Crescent Cap BDC Inc(CCAP) | COM | 225655109 | $520.0K | 47,621 | 0.1% |
| Sound Point Meridian Cap Inc(SPMC) | COMMON STOCK | 83617A108 | $520.1K | 52,537 | 0.1% |
| Stellus Cap Invt Corp(SCM) | COM | 858568108 | $523.2K | 62,135 | 0.1% |
| Invesco SR Income TR(VVR) | COM | 46131H107 | $529.6K | 176,549 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $546.6K | 11,867 | 0.1% |
| Oaktree Specialty Lending(OCSL) | COM | 67401P405 | $559.1K | 46,824 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $588.6K | 49,129 | 0.1% |
| Sellas Life Sciences Group I(SLS) | COM NEW | 81642T209 | $616.8K | 41,788 | 0.1% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $621.9K | 13,220 | 0.1% |
| Goldman Sachs BDC Inc(GSBD) | SHS | 38147U107 | $642.2K | 67,747 | 0.1% |
| Cion Invt Corp(CION) | COM | 17259U204 | $673.2K | 108,061 | 0.2% |
| Runway Growth Finance Corp(RWAY) | COM | 78163D100 | $678.9K | 121,023 | 0.2% |
| Pennantpark Invt Corp(PNNT) | COM | 708062104 | $750.4K | 216,246 | 0.2% |
| FS KKR Cap Corp(FSK) | COM | 302635206 | $784.8K | 74,745 | 0.2% |
| XAI Floating Rate & Alter in(XFLT) | COM SHS BENF INT | 98400T304 | $802.4K | 45,722 | 0.2% |
| BlackRock TCP Capital Corp(TCPC) | COM | 09259E108 | $869.7K | 258,829 | 0.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $936.3K | 32,419 | 0.2% |
| Prospect Cap Corp(PSEC) | COM | 74348T102 | $990.1K | 428,612 | 0.2% |
| OFS Credit Company Inc(OCCIEUR) | COM | 67111Q107 | $1.0M | 392,323 | 0.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.0M | 204,373 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.1M | 283,630 | 0.3% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $1.1M | 4,557 | 0.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.2M | 2,130 | 0.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.2M | 18,771 | 0.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $1.2M | 141,642 | 0.3% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.2M | 285,020 | 0.3% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $1.2M | 69,885 | 0.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.2M | 20,784 | 0.3% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.2M | 21,887 | 0.3% |
| Horizon Technology FIN Corp(HRZN) | COM | 44045A102 | $1.2M | 252,455 | 0.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $1.2M | 12,844 | 0.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $1.2M | 112,139 | 0.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.2M | 7,279 | 0.3% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $1.2M | 33,746 | 0.3% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $1.2M | 130,955 | 0.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $1.2M | 73,507 | 0.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $1.3M | 47,698 | 0.3% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $1.3M | 4,397 | 0.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.3M | 5,813 | 0.3% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $1.3M | 15,870 | 0.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $1.3M | 15,476 | 0.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.3M | 33,736 | 0.3% |
| Omeros Corp(OMER) | COM | 682143102 | $1.3M | 133,129 | 0.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.3M | 11,884 | 0.3% |